Grufity logo
Grufity logo

Latest Ikarian Capital, LLC Stock Portfolio

$1.23Billion | No. of Holdings #127

Ikarian Capital, LLC Performance

2026 Q1-0.37%
YTD-0.37%
2025+26.73%

About Ikarian Capital, LLC and 13F Hedge Fund Stock Holdings

Ikarian Capital, LLC is a hedge fund based in Dallas, TX. On 2026-05-15, the fund reported it's updated stock portfolio. In the 13F Holdings report, Ikarian Capital, LLC reported an equity portfolio of $1.2 Billions as of 31 Mar, 2026. <br><br> The top stock holdings of Ikarian Capital, LLC are TERN, KOD, . The fund has invested 6.2% of it's portfolio in TERNS PHARMACEUTICALS INC and 3.9% of portfolio in KODIAK SCIENCES INC. <br><br> The fund managers got completely rid off AMGEN INC (AMGN), CYTOMX THERAPEUTICS INC (CTMX) and CELCUITY INC (CELC) stocks. They significantly reduced their stock positions in COMPASS THERAPEUTICS INC (CMPX), JAZZ PHARMACEUTICALS PLC (JAZZ) and ABIVAX SA. Ikarian Capital, LLC opened new stock positions in ALUMIS INC, CELLDEX THERAPEUTICS INC NEW (CLDX) and BRIDGEBIO PHARMA INC (BBIO). The fund showed a lot of confidence in some stocks as they added substantially to ULTRAGENYX PHARMACEUTICAL IN (RARE), OVID THERAPEUTICS INC (OVID) and SOLENO THERAPEUTICS INC (SLNO).
Ikarian Capital, LLC Equity Portfolio Value
Last Reported on: 15 May, 2026
$1.23Billion
  as of May 15, 2026

Ikarian Capital, LLC Annual Return Estimates Vs S&P 500

Our best estimate is that Ikarian Capital, LLC made a return of -0.37% in the last quarter. In trailing 12 months, it's portfolio return was 50.28%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
alumis inc26,734,500
celldex therapeutics inc new14,630,800
bridgebio pharma inc11,890,500
oruka therapeutics inc11,871,100
ani pharmaceuticals inc11,310,800
palvella therapeutics inc ne8,055,630
vera therapeutics inc8,046,000
ocugen inc7,172,980
New stocks bought by Ikarian Capital, LLC

Additions

Ticker% Inc.
ultragenyx pharmaceutical in3,708
ovid therapeutics inc1,069
soleno therapeutics inc400
acumen pharmaceuticals inc314
harrow inc196
contineum therapeutics inc185
inventiva sa184
surrozen inc163
Additions to existing portfolio by Ikarian Capital, LLC

Reductions

Ticker% Reduced
compass therapeutics inc-97.75
jazz pharmaceuticals plc-92.23
abivax sa-72.02
sensei biotherapeutics inc-70.25
nuvalent inc-60.41
forte biosciences inc-60.34
insmed inc-54.87
eli lilly & co-52.61
Ikarian Capital, LLC reduced stake in above stock

Sold off

Ticker$ Sold
cytomx therapeutics inc-13,515,300
ventyx biosciences inc-8,657,100
erasca inc-2,735,670
adma biologics inc-4,283,740
mineralys therapeutics inc-7,258,000
cg oncology inc-8,282,120
ptc therapeutics inc-9,013,190
tg therapeutics inc-3,514,690
Ikarian Capital, LLC got rid off the above stocks

Sector Distribution

Ikarian Capital, LLC has about 70.7% of it's holdings in Healthcare sector.

  • Healthcare
  • Others
Sector%
Healthcare70.7
Others28.8

Market Cap. Distribution

Ikarian Capital, LLC has about 6.4% of it's portfolio invested in the large-cap and mega-cap stocks.

  • UNALLOCATED
  • SMALL-CAP
  • MID-CAP
  • MICRO-CAP
  • LARGE-CAP
  • NANO-CAP
Category%
UNALLOCATED28.8
SMALL-CAP26
MID-CAP24.6
MICRO-CAP10.5
LARGE-CAP6.4
NANO-CAP2.8

Stocks belong to which Index?

About 43.5% of the stocks held by Ikarian Capital, LLC either belong to S&P 500 or RUSSELL 2000 index.

  • Others
  • RUSSELL 2000
Index%
Others55.7
RUSSELL 200043.5
Top 5 Winners (%)%
SNSE
sensei biotherapeutics inc
126.8 %
IMUX
immunic inc
108.0 %
PHGE
biomx inc
100.8 %
MGNX
macrogenics inc
79.5 %
ONTX
traws pharma inc
62.0 %
Top 5 Winners ($)$
TERN
terns pharmaceuticals inc
18.8 M
KOD
kodiak sciences inc
10.1 M
RLMD
relmada therapeutics inc
6.1 M
PCVX
vaxcyte inc
4.8 M
TENX
tenax therapeutics inc
3.8 M
Top 5 Losers (%)%
IOBT
io biotech inc
-90.4 %
GCTK
glucotrack inc
-83.2 %
fractyl health inc
-79.2 %
PEPG
pepgen inc
-72.8 %
SHPH
shuttle pharmactcls hldgs in
-62.3 %
Top 5 Losers ($)$
OLMA
olema pharmaceuticals inc
-6.8 M
maze therapeutics inc
-5.9 M
HROW
harrow inc
-5.0 M
FULC
fulcrum therapeutics inc
-4.4 M
abivax sa
-4.4 M

Ikarian Capital, LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Ikarian Capital, LLC

Ikarian Capital, LLC has 127 stocks in it's portfolio. About 23.4% of the portfolio is in top 10 stocks. OLMA proved to be the most loss making stock for the portfolio. TERN was the most profitable stock for Ikarian Capital, LLC last quarter.

$699.01MTotal Value
145Positions
15 May, 2026Last Reported
Current holdings of Current Stock Holdings of Ikarian Capital, LLC, last reported on 15 May, 2026. Select a row with a linked ticker to view its historical trend.
ExpandHoldingsorted ascending% PortfolioShares Held$ Value% Change
CMMB
Chemomab Therapeutics Ltd

Chemomab Therapeutics Ltd

CMMB
Ikarian Capital, LLC's holding in Chemomab Therapeutics Ltd over time
0.01%51,793
$81.3K
0.01%
unchanged 0 percentunchanged
CMPS
Compass Pathways Plc

Compass Pathways Plc

CMPS
Ikarian Capital, LLC's holding in Compass Pathways Plc over time
0.3%675,000
$3.73M
0.3%
increased 68.75 percentadded